HAN, TAE DONG,TAK, HEE JAE,KIM, EUN KYUNG,CHOI, SU BIN,PARK, SOL,KIM, DONG HOON,KIM, SO YOUNG,CHOI, HYUN HO,KIM, TAE WANG,JU, MI KYEONG,HA, NA RY,LEE, EUI CHUL
申请号:
CA3093057
公开号:
CA3093057A1
申请日:
2019.03.20
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present technology provides triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).